Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)

ClinicalTrials.gov ID: NCT00268216

Public ClinicalTrials.gov record NCT00268216. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 1:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Long-term Effects of Salmeterol/Fluticasone Propionate (Seretide tm) 50/500mcg BD, Salmeterol 50mcg BD and Fluticasone Propionate 500mcg BD, All Delivered Via the Diskus tm/Accuhaler tm Inhaler, on Mortality and Morbidity of Subjects With Chronic Obstructive Pulmonary Disease (COPD) Over 3 Years of Treatment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to see if fluticasone 500mcg/salmeterol 50mcg can improve the survival of subjects with COPD and also assess the long term safety profile of this drug.

Study identification

NCT ID
NCT00268216
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
6,228 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2000
Primary completion
Oct 31, 2005
Completion
Oct 31, 2005
Last update posted
Jan 19, 2017

2000 – 2005

United States locations

U.S. sites
190
U.S. states
42
U.S. cities
155
Facility City State ZIP Site status
GSK Investigational Site Birmingham Alabama 35235
GSK Investigational Site Birmingham Alabama 35294-7340
GSK Investigational Site Birmingham Alabama 35294
GSK Investigational Site Jasper Alabama 35501
GSK Investigational Site Mobile Alabama 36608
GSK Investigational Site Ozark Alabama 36360
GSK Investigational Site Phoenix Arizona 85006
GSK Investigational Site Phoenix Arizona 85008
GSK Investigational Site Scottsdale Arizona 85251
GSK Investigational Site Berkeley California 94705
GSK Investigational Site Burbank California 91505
GSK Investigational Site Encinitas California 92024
GSK Investigational Site Fresno California 93710
GSK Investigational Site Fullerton California 92835
GSK Investigational Site Long Beach California 90822
GSK Investigational Site Los Angeles California 90033
GSK Investigational Site Los Angeles California 90048
GSK Investigational Site Rancho Mirage California 92270
GSK Investigational Site Riverside California 92506
GSK Investigational Site San Diego California 92103-6204
GSK Investigational Site San Diego California 92103
GSK Investigational Site San Diego California 92117
GSK Investigational Site San Diego California 92120
GSK Investigational Site San Diego California 92123
GSK Investigational Site San Francisco California 94102
GSK Investigational Site San Luis Obispo California 93401
GSK Investigational Site Sepuldeva California 91343
GSK Investigational Site Stockton California 95207
GSK Investigational Site Sunnyvale California 94086
GSK Investigational Site Sylmar California 91342-1495
GSK Investigational Site Vista California 92083
GSK Investigational Site Walnut Creek California 94598
GSK Investigational Site Arvada Colorado 80002
GSK Investigational Site Denver Colorado 80206
GSK Investigational Site Denver Colorado 80218
GSK Investigational Site Fort Collins Colorado 80528
GSK Investigational Site Longmont Colorado 80501
GSK Investigational Site Loveland Colorado 80538
GSK Investigational Site Pueblo Colorado 81001
GSK Investigational Site Wheat Ridge Colorado 80033
GSK Investigational Site Hartford Connecticut 06105
GSK Investigational Site Stamford Connecticut 06902
GSK Investigational Site Altamonte Springs Florida 32701
GSK Investigational Site Atlantis Florida 33462
GSK Investigational Site Bay Pines Florida 33744
GSK Investigational Site Brandon Florida 33511
GSK Investigational Site Clearwater Florida 33756
GSK Investigational Site Fort Lauderdale Florida 33316
GSK Investigational Site Jacksonville Florida 32205
GSK Investigational Site Jacksonville Florida 32216
GSK Investigational Site Largo Florida 33770
GSK Investigational Site Longwood Florida 32779
GSK Investigational Site Loxahatchee Groves Florida 33470
GSK Investigational Site Miami Florida 33136
GSK Investigational Site Pace Florida 32571
GSK Investigational Site Palm Springs Florida 33461
GSK Investigational Site Pensacola Florida 32514
GSK Investigational Site Sarasota Florida 34239
GSK Investigational Site Tamarac Florida 33321
GSK Investigational Site Tampa Florida 33613
GSK Investigational Site West Palm Beach Florida 33409
GSK Investigational Site Zephyrhills Florida 33540
GSK Investigational Site Atlanta Georgia 30342
GSK Investigational Site Augusta Georgia 30901
GSK Investigational Site Blue Ridge Georgia 30513
GSK Investigational Site Decatur Georgia 30033
GSK Investigational Site Marietta Georgia 30066
GSK Investigational Site Rome Georgia 30165
GSK Investigational Site Roswell Georgia 30076
GSK Investigational Site Coeur d'Alene Idaho 83814
GSK Investigational Site Champaign Illinois 61821
GSK Investigational Site Chicago Illinois 60612-3824
GSK Investigational Site Chicago Illinois 60612-7323
GSK Investigational Site Hines Illinois 60141-5099
GSK Investigational Site North Chicago Illinois 60064
GSK Investigational Site Peoria Illinois 61602
GSK Investigational Site South Bend Indiana 46617
GSK Investigational Site Dubuque Iowa 52001
GSK Investigational Site Wichita Kansas 67207
GSK Investigational Site Wichita Kansas 67208
GSK Investigational Site Lexington Kentucky 40536
GSK Investigational Site Louisville Kentucky 40215
GSK Investigational Site Lafayette Louisiana 70503
GSK Investigational Site Shreveport Louisiana 71103
GSK Investigational Site Sunset Louisiana 70584
GSK Investigational Site Auburn Maine 04210
GSK Investigational Site Baltimore Maryland 21204
GSK Investigational Site Baltimore Maryland 21224
GSK Investigational Site Boston Massachusetts 02135
GSK Investigational Site Swansea Massachusetts 02777
GSK Investigational Site Cadillac Michigan 49601
GSK Investigational Site Livonia Michigan 48152
GSK Investigational Site Saint Joseph Michigan 49085
GSK Investigational Site Traverse City Michigan 49684
GSK Investigational Site Edina Minnesota 55438
GSK Investigational Site Minneapolis Minnesota 55417
GSK Investigational Site Jackson Mississippi 39202
GSK Investigational Site Chesterfield Missouri 63017
GSK Investigational Site Jefferson City Missouri 65109
GSK Investigational Site Kansas City Missouri 64108
GSK Investigational Site Saint Charles Missouri 63301
GSK Investigational Site St Louis Missouri 63110
GSK Investigational Site St Louis Missouri 63141
GSK Investigational Site Billings Montana 59102
GSK Investigational Site Omaha Nebraska 68105
GSK Investigational Site Omaha Nebraska 68124
GSK Investigational Site Omaha Nebraska 68134
GSK Investigational Site Omaha Nebraska 68198-2456
GSK Investigational Site Omaha Nebraska 68198
GSK Investigational Site Las Vegas Nevada 89104
GSK Investigational Site Gilford New Hampshire 3249
GSK Investigational Site Lebanon New Hampshire 03756
GSK Investigational Site East Orange New Jersey 07018
GSK Investigational Site New Brunswick New Jersey 8901
GSK Investigational Site Newark New Jersey 07112
GSK Investigational Site Summit New Jersey 07091
GSK Investigational Site Trenton New Jersey 8629
GSK Investigational Site Albuquerque New Mexico 87108
GSK Investigational Site Albany New York 12205
GSK Investigational Site Albany New York 12208
GSK Investigational Site Bronxville New York 10708
GSK Investigational Site Brooklyn New York 11217
GSK Investigational Site Buffalo New York 14221
GSK Investigational Site Great Neck New York 11023
GSK Investigational Site Mineola New York 11501
GSK Investigational Site New York New York 10011
GSK Investigational Site New York New York 10016
GSK Investigational Site New York New York 10025
GSK Investigational Site New York New York 10029
GSK Investigational Site Chapel Hill North Carolina 27514
GSK Investigational Site Charlotte North Carolina 28207
GSK Investigational Site Elizabeth City North Carolina 27909
GSK Investigational Site Greenville North Carolina 27834
GSK Investigational Site High Point North Carolina 27262
GSK Investigational Site Wilmington North Carolina 28401
GSK Investigational Site Winston-Salem North Carolina 27103
GSK Investigational Site Winston-Salem North Carolina 27157
GSK Investigational Site Cincinnati Ohio 45219
GSK Investigational Site Cincinnati Ohio 45267-0405
GSK Investigational Site Cleveland Ohio 44024
GSK Investigational Site Franklin Ohio 45005
GSK Investigational Site Toledo Ohio 43614-5809
GSK Investigational Site Toledo Ohio 43617
GSK Investigational Site Oklahoma City Oklahoma 73104
GSK Investigational Site Lake Oswego Oregon 97035
GSK Investigational Site Medford Oregon 97504
GSK Investigational Site Portland Oregon 97213-2281
GSK Investigational Site Portland Oregon 97213
GSK Investigational Site Allentown Pennsylvania 18104
GSK Investigational Site Downington Pennsylvania 19335
GSK Investigational Site Doylestown Pennsylvania 8901
GSK Investigational Site Erie Pennsylvania 16508
GSK Investigational Site Philadelphia Pennsylvania 19129
GSK Investigational Site Philadelphia Pennsylvania 19140
GSK Investigational Site Philadelphia Pennsylvania 19148
GSK Investigational Site Pittsburgh Pennsylvania 15213
GSK Investigational Site Pittsburgh Pennsylvania 15218
GSK Investigational Site Ridley Park Pennsylvania 19078
GSK Investigational Site Cranston Rhode Island 02920
GSK Investigational Site East Providence Rhode Island 02914
GSK Investigational Site Charleston South Carolina 29403
GSK Investigational Site Charleston South Carolina 29406-7108
GSK Investigational Site Greer South Carolina 29651
GSK Investigational Site Simpsonville South Carolina 29681
GSK Investigational Site Spartanburg South Carolina 29303
GSK Investigational Site Bristol Tennessee 37620
GSK Investigational Site Johnson City Tennessee 37601
GSK Investigational Site Kingsport Tennessee 37660
GSK Investigational Site Milan Tennessee 38372
GSK Investigational Site Morristown Tennessee 37813
GSK Investigational Site Corsicana Texas 75110
GSK Investigational Site Houston Texas 77024
GSK Investigational Site Houston Texas 77030
GSK Investigational Site Houston Texas 77074
GSK Investigational Site San Antonio Texas 78205
GSK Investigational Site San Antonio Texas 78217
GSK Investigational Site Salt Lake City Utah 84102
GSK Investigational Site Chesapeake Virginia 23320
GSK Investigational Site Fredericksburg Virginia 22401
GSK Investigational Site Richmond Virginia 23225
GSK Investigational Site Richmond Virginia 23249
GSK Investigational Site Roanoke Virginia 24016
GSK Investigational Site Virginia Beach Virginia 23454
GSK Investigational Site Bellingham Washington 98226
GSK Investigational Site Spokane Washington 99202
GSK Investigational Site Spokane Washington 99204
GSK Investigational Site Charleston West Virginia 25304
GSK Investigational Site Huntington West Virginia 25701-1693
GSK Investigational Site La Crosse Wisconsin 54601
GSK Investigational Site Madison Wisconsin 53705

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 269 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00268216, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 19, 2017 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00268216 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →